Loading stock data…
PNTG
$32.77+1.39 (+4.43%)
After Hours$32.77+0.00 (+0.00%)· Last close Jun 9
The Pennant Group, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
The Pennant Group, Inc. in the Healthcare sector is trading at $32.77. Wall Street consensus targets $40.83 (6 analysts), implying a +24.6% move over the next 12 months. The stock is currently 13% below its 52-week high of $37.54, remaining 13.0% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 95/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +24.6% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$32.77
Potential Downside
0%
Whystock Fair Value$32.77
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursin...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
-
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
8.76%
Volume
Today's trading volume
314,380
Recent News
A Look At Pennant Group (PNTG) Valuation After Expanded Hartford HealthCare Partnership
Pennant Group (PNTG) shares moved after the company expanded its partnership with Hartford HealthCare, aiming to unify and grow home based care services across Connecticut, where the collaboration has already supported improved clinical outcomes. See our latest analysis for Pennant Group. The 5.28% 1 day share price gain to US$31.71 came after a tougher recent patch, with the 30 day share price return down 2.52% and year to date share price return at 13.94%. The 3 year total shareholder...
Pennant Group’s New Deals Test Growth Ambitions In Senior And Home Care
Pennant Group, NasdaqGS:PNTG, has taken over operations of Memory Care of Contra Costa, marking its first senior living move into California. The company is also expanding its collaboration with Hartford HealthCare to form a unified home based care entity in Connecticut. These steps extend Pennant's reach across both senior living and home based services in new geographic areas. Pennant Group enters these agreements with its shares at $31.71 and a year to date return of 13.9%. Over the past...
Here is Why Growth Investors Should Buy The Pennant Group (PNTG) Now
The Pennant Group (PNTG) possesses solid growth attributes, which could help it handily outperform the market.
Wall Street Analysts Believe The Pennant Group (PNTG) Could Rally 27.59%: Here's is How to Trade
The average of price targets set by Wall Street analysts indicates a potential upside of 27.6% in The Pennant Group (PNTG). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Does Pennant Group’s (PNTG) Zacks Upgrade Hint At A Deeper Shift In Earnings Quality?
In recent days, The Pennant Group, Inc. received an upgrade to a Zacks Rank #2 (Buy), reflecting a shift toward higher analyst earnings estimates and a more favorable assessment of its near-term outlook. This upgrade highlights how changing expectations for Pennant’s earnings power can influence perceptions of its underlying business quality and future prospects. We’ll now explore how this earnings estimate upgrade could affect Pennant Group’s existing investment narrative and risk‑reward...